When Does Process Intensification Just Become Too Complex to Control?
Just filing a few more notes on the Yale Green Processing conference from last week. Afternoon sessions during the first day focused on the "hot" topic of continuous processing and use of process...
View ArticleBIO 2008 - DSM Bio Looks Downstream
Karen King, President of DSM Biologics, discussed the implications of the company's recent joint venture with Crucell, which has increased upstream productivity. The technology, PER.C, has reportedly...
View ArticleLanger: Breakthroughs Boosting Cell Culture Capacity
The news today that DSM Biologics and Crucell N.V. had again scaled up production of the PER.C6 cell line was another sign that biopharma cell culture capacity concerns are (probably) a thing of the...
View ArticleSustainability: Pharma Reaches Above the Low-Hanging Fruit
Those who cover green and sustainability issues know that Pharma is pretty progressive. No, the industry's not perfect, certainly, but many of its leading companies also make it a point to be leaders...
View Article
